Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Triadafilopoulos, G; Taddei, A; Bechi, P; Freschi, G; Ringressi, MN; Degli'innocenti, DR; Castiglione, F; Masini, E; Majewski, M; Wallner, G; Sarosiek, J; Dillon, JF; McCallum, RC; Dvorak, K; Goldman, A; Woodland, P; Sifrim, D; Richter, JE; Vieth, M; Neumann, H; Langner, C; Ishimura, N; Amano, Y; Felix, VN.
Barrett's esophagus: proton pump inhibitors and chemoprevention I.
Ann N Y Acad Sci. 2011; 1232(1): 93-113. Doi: 10.1111/j.1749-6632.2011.06047.x
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Langner Cord
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
The following on proton pump inhibitors and chemoprevention in Barrett's esophagus includes commentaries on normalization of esophageal refluxate; the effects of 5-HT(4) agonists on EGF secretion and of lubripristone on chloride channels agents; the role of Campylobacter toxin production; the deleterious effects of unconjugated bile acids; the role of baclofen in nonacid reflux; the threshold for adequate esophageal acid exposure; the effects of proton pump inhibitor (PPI) therapy on normalization of esophageal pH and on cell proliferation; the role of the phenotype of cellular proliferation on the effects of PPI therapy; and the value of Symptom Index and Symptom Association Probability in the evaluation of potential response to treatment.
Find related publications in this database (using NLM MeSH Indexing)
Barrett Esophagus - drug therapy
Chemoprevention -
Humans -
Proton Pump Inhibitors - therapeutic use

Find related publications in this database (Keywords)
Barrett's treatment
omeprazole
duodenogastroesophageal reflux
dysplasia
Symptom Sensitivity Index
Symptom Association Probability
antireflux surgery
PPI
mucin phenotype
pH control
esomeprazole
basal cell layer
hyperplasia
stromal papillae
GABA(B) baclofen
lesogaberan
weakly acidic reflux
TLESR
Campylobacter
microbiota
prostone
5-HT4
TGF-alpha
GERD
EGF
mucosal protection
CDX2
Barrett's cell lines
© Med Uni GrazImprint